163 related articles for article (PubMed ID: 37029008)
1. Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter ≤ 2 cm.
Wo Y; Li H; Chen Z; Peng Y; Zhang Y; Ye T; Jiang W; Sun Y
Clin Lung Cancer; 2023 Jul; 24(5):437-444. PubMed ID: 37029008
[TBL] [Abstract][Full Text] [Related]
2. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
[TBL] [Abstract][Full Text] [Related]
3. Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial.
Zhang Y; Deng C; Zheng Q; Qian B; Ma J; Zhang C; Jin Y; Shen X; Zang Y; Guo Y; Fu F; Li H; Zheng S; Wu H; Huang Q; Wang S; Liu Q; Ye T; Sun Y; Zhang Y; Xiang J; Hu H; Li Y; Chen H
J Thorac Oncol; 2023 Jul; 18(7):931-939. PubMed ID: 36841542
[TBL] [Abstract][Full Text] [Related]
4. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
[TBL] [Abstract][Full Text] [Related]
6. Significance of Lymphadenectomy in Part-Solid Lung Adenocarcinoma: Propensity Score Matched Analysis.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2018 Oct; 106(4):989-997. PubMed ID: 29852148
[TBL] [Abstract][Full Text] [Related]
7. [Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer].
Zhang Z; Mao Y; He J; Gao S; Cheng G; Liu X; Fang D; Li J; Wang Y; Wang D; Mu J; Xue Q; Gao Y; Zhao J; Zhang L; Huang J; Wang B; Ding N
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):536-40. PubMed ID: 25327661
[TBL] [Abstract][Full Text] [Related]
8. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
[TBL] [Abstract][Full Text] [Related]
9. Non-adjacent interlobar lymph node metastasis distant from small-sized peripheral non-small cell lung cancer.
Maniwa T; Kimura T; Ohue M; Shintani Y; Okami J
Surg Today; 2022 Dec; 52(12):1746-1752. PubMed ID: 35501495
[TBL] [Abstract][Full Text] [Related]
10. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
Ann Surg Oncol; 2021 Nov; 28(12):7162-7171. PubMed ID: 34218364
[TBL] [Abstract][Full Text] [Related]
11. Importance of Lymph Node Evaluation in ≤2-cm Pure-Solid Non-Small Cell Lung Cancer.
Choi S; Yoon DW; Shin S; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
Ann Thorac Surg; 2024 Mar; 117(3):586-593. PubMed ID: 36608755
[TBL] [Abstract][Full Text] [Related]
12. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
[TBL] [Abstract][Full Text] [Related]
13. Is lobe specific lymph node dissection adequate for cN0-1 non-small cell lung cancer?
Fang L; Xu J; Ye B; Yu G; Chen G; Yang J
J Cardiothorac Surg; 2020 Feb; 15(1):46. PubMed ID: 32106870
[TBL] [Abstract][Full Text] [Related]
14. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
[TBL] [Abstract][Full Text] [Related]
15. Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer.
Zhang Y; Fu F; Wen Z; Deng L; Wang S; Li Y; Chen H
Ann Thorac Surg; 2020 Apr; 109(4):1061-1068. PubMed ID: 31863756
[TBL] [Abstract][Full Text] [Related]
16. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter.
Fang C; Xiang Y; Han W
BMC Surg; 2022 Apr; 22(1):153. PubMed ID: 35488235
[TBL] [Abstract][Full Text] [Related]
17. Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers.
Yin J; Xi J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q
Clin Lung Cancer; 2021 Jul; 22(4):324-331. PubMed ID: 33789831
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
[TBL] [Abstract][Full Text] [Related]
19. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
Ota S; Inaba H; Yoshida H
Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
